Methods for increasing polypeptide production
AssigneeImmunex Corporation
InventorsKirk P. Van Ness, Michael T. Trentalange, Bradley D. Dell, Jeffrey T. McGrew
Life of this patent
Estimating the term…
Abstract
The invention provides methods of increasing the production of polypeptides, optionally recombinant polypeptides, from mammalian cells using xanthine derivatives or hybrid polar compounds and cultures containing the same. Combinations of inducers including a hybrid polar compound and/or a xanthine derivative and/or an alkanoic acid can also be used, optionally at temperatures less than 37° C.
Claims69
A method for producing a polypeptide comprising:
- culturing a mammalian cell line in a growth phase followed by a production phase, wherein the production phase occurs at a temperature of less than 37° C.;
- and
- adding to the culture medium during the production phase a xanthine derivative;
- wherein the addition of the xanthine derivative increases production of the polypeptide;
- and
- wherein the mammalian cell line is selected from the group consisting of a mammalian cell line that has been genetically engineered to produce the polypeptide and a hybridoma cell line that produces an antibody.
A method for producing a recombinant polypeptide comprising:
- culturing a CHO cell line that has been genetically engineered to produce the recombinant polypeptide;
- and
- adding to the culture medium at least one xanthine derivative selected from the group consisting of theobromine and caffeine,
- wherein the addition of the xanthine derivative increases the production of the recombinant polypeptide.
A culture comprising a CHO cell genetically engineered to produce a polypeptide, a production medium, and a xanthine derivative selected from the group consisting of caffeine, theobromine, and pentoxyphylline.
A method for producing a recombinant polypeptide comprising
- culturing a mammalian cell line at a temperature from about 29° C. to about 36° C. and
- adding a hybrid polar compound to the culture medium,
- wherein the mammalian cell line has been genetically engineered to produce the recombinant polypeptide and
- wherein the addition of the hybrid polar compound increases the production of the recombinant polypeptide.
A method for producing a polypeptide comprising
- culturing a mammalian cell line that can express the polypeptide in a growth phase at a first temperature from about 35° C. to about 38° C., and then
- culturing the mammalian cell line in a production phase at a second temperature from about 30° C. to 34° C. in a medium comprising a hybrid polar compound.
A method for producing a polypeptide comprising culturing mammalian cells that can produce the polypeptide in a medium comprising between about 0.1 millimolar and about 5 millimolar hexamethylene bisacetamide, from about 0.1 millimolar to about 2 millimolar butyric acid, and from about 0.1 millimolar to about 4 millimolar caffeine at a temperature from about 30° C. to about 36° C.
A cell culture comprising a CHO cell line that has been genetically engineered to produce a polypeptide and a production medium comprising hexamethylene bisacetamide, wherein the culture is incubated at a temperature from about 30° C. to 36° C. for at least about 5 days.
Dependencies are inferred from the claim text.